Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | FNTA | P49354 | 4/20 | 0.51 |
| ▸ | FNTB | P49356 | 4/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 4/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.44 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7086705 | 1.00 | KMT2A (0.59) | KMT2ASMN1; SMN2FNTAFNTBPTGS1 | |
| SCHEMBL6927080 | 1.00 | KMT2A (0.59) | KMT2ASMN1; SMN2FNTAFNTBPTGS1 | |
| Hydrochloric Acid SCHEMBL7089814 | 0.99 | KMT2A (0.57) | KMT2ASMN1; SMN2FNTAFNTBPTGS1 | |
| Hydrochloric Acid SCHEMBL20546770 | 0.99 | KMT2A (0.57) | KMT2ASMN1; SMN2FNTAFNTBPTGS1 | |
| Hydrochloric Acid SCHEMBL7091447 | 0.99 | KMT2A (0.57) | KMT2ASMN1; SMN2FNTAFNTBPTGS1 | |
| SCHEMBL7087851 | 0.90 | KMT2A (0.70) | KMT2ASMN1; SMN2FNTAFNTBPTGS1 | |
| SCHEMBL7088219 | 0.90 | KMT2A (0.70) | KMT2ASMN1; SMN2FNTAFNTBPTGS1 | |
| SCHEMBL6922512 | 0.90 | KMT2A (0.70) | KMT2ASMN1; SMN2FNTAFNTBPTGS1 | |
| Hydrochloric Acid SCHEMBL20546996 | 0.89 | KMT2A (0.59) | KMT2ASMN1; SMN2PTGS1FFAR1ALOX5 | |
| Hydrochloric Acid SCHEMBL20546995 | 0.89 | KMT2A (0.59) | KMT2ASMN1; SMN2PTGS1FFAR1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1386166-A2 | ANTI-EPILEPTOGENIC AGENTS | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2004-02-04 | — | — | EP | claimed |
| US-20030194375-A1 | Administering 3-aminopropionic acid derivative as anticonvulsant | QUEEN'S UNIVERSITY AT KINGSTON AND NEUROCHEM, INC. | 2003-10-16 | — | — | US | claimed |
| WO-2002073208-A2 | ANTI-EPILEPTOGENIC AGENTS | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2002-09-19 | — | — | WO | claimed |
| US-20030194375-A1 | Administering 3-aminopropionic acid derivative as anticonvulsant | QUEEN'S UNIVERSITY AT KINGSTON AND NEUROCHEM, INC. | 2003-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030194375-A1 | Administering 3-aminopropionic acid derivative as anticonvulsant | SLC1A2, SLC1A1, SLC1A3 | KMT2A 1066/4885SMN1; SMN2 3205/4885FNTA 601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.